Publications

  1. Ophey, A, Giehl, K, Rehberg, S, Eggers, C, Reker, P, van Eimeren, T et al.. Effects of working memory training in patients with Parkinson's disease without cognitive impairment: A randomized controlled trial. Parkinsonism Relat. Disord. 2020;72 :13-22. doi: 10.1016/j.parkreldis.2020.02.002. PubMed PMID:32078917 .
  2. Ruppert, MC, Greuel, A, Tahmasian, M, Schwartz, F, Stürmer, S, Maier, F et al.. Network degeneration in Parkinson's disease: multimodal imaging of nigro-striato-cortical dysfunction. Brain. 2020;143 (3):944-959. doi: 10.1093/brain/awaa019. PubMed PMID:32057084 .
  3. Giehl, K, Ophey, A, Reker, P, Rehberg, S, Hammes, J, Barbe, MT et al.. Effects of Home-Based Working Memory Training on Visuo-Spatial Working Memory in Parkinson's Disease: A Randomized Controlled Trial. J Cent Nerv Syst Dis. 2020;12 :1179573519899469. doi: 10.1177/1179573519899469. PubMed PMID:32002011 PubMed Central PMC6966247.
  4. van Eimeren, T, Drzezga, A. From molecules to system failure: translational frontiers of multimodal imaging in neurodegenerative diseases. Eur. J. Nucl. Med. Mol. Imaging. 2019;46 (13):2816-2818. doi: 10.1007/s00259-019-04562-7. PubMed PMID:31667539 .
  5. Dietlein, F, Kobe, C, Hohberg, M, Zlatopolskiy, BD, Krapf, P, Endepols, H et al.. Intraindividual comparison of F-PSMA-1007 with renally excreted PSMA ligands for PSMA-PET imaging in patients with relapsed prostate cancer. J. Nucl. Med. 2019; :. doi: 10.2967/jnumed.119.234898. PubMed PMID:31628219 .
  6. Respondek, G, Grimm, MJ, Piot, I, Arzberger, T, Compta, Y, Englund, E et al.. Validation of the movement disorder society criteria for the diagnosis of 4-repeat tauopathies. Mov. Disord. 2020;35 (1):171-176. doi: 10.1002/mds.27872. PubMed PMID:31571273 .
  7. Baldermann, JC, Bohn, KP, Hammes, J, Schüller, CB, Visser-Vandewalle, V, Drzezga, A et al.. Local and Global Changes in Brain Metabolism during Deep Brain Stimulation for Obsessive-Compulsive Disorder. Brain Sci. 2019;9 (9):. doi: 10.3390/brainsci9090220. PubMed PMID:31480355 PubMed Central PMC6770477.
  8. Hohberg, M, Kobe, C, Krapf, P, Täger, P, Hammes, J, Dietlein, F et al.. Biodistribution and radiation dosimetry of [F]-JK-PSMA-7 as a novel prostate-specific membrane antigen-specific ligand for PET/CT imaging of prostate cancer. EJNMMI Res. 2019;9 (1):66. doi: 10.1186/s13550-019-0540-7. PubMed PMID:31346821 PubMed Central PMC6658635.
  9. Sehlin, D, Syvänen, S, MINC faculty. Engineered antibodies: new possibilities for brain PET?. Eur. J. Nucl. Med. Mol. Imaging. 2019;46 (13):2848-2858. doi: 10.1007/s00259-019-04426-0. PubMed PMID:31342134 PubMed Central PMC6879437.
  10. Dietlein, F, Hohberg, M, Kobe, C, Zlatopolskiy, BD, Krapf, P, Endepols, H et al.. An F-Labeled PSMA Ligand for PET/CT of Prostate Cancer: First-in-Humans Observational Study and Clinical Experience with F-JK-PSMA-7 During the First Year of Application. J. Nucl. Med. 2020;61 (2):202-209. doi: 10.2967/jnumed.119.229542. PubMed PMID:31324713 .
  11. Bischof, GN, Ewers, M, Franzmeier, N, Grothe, MJ, Hoenig, M, Kocagoncu, E et al.. Connectomics and molecular imaging in neurodegeneration. Eur. J. Nucl. Med. Mol. Imaging. 2019;46 (13):2819-2830. doi: 10.1007/s00259-019-04394-5. PubMed PMID:31292699 .
  12. Riederer, P, Berg, D, Casadei, N, Cheng, F, Classen, J, Dresel, C et al.. α-Synuclein in Parkinson's disease: causal or bystander?. J Neural Transm (Vienna). 2019;126 (7):815-840. doi: 10.1007/s00702-019-02025-9. PubMed PMID:31240402 .
  13. Hoenig, MC, Bischof, GN, Onur, ÖA, Kukolja, J, Jessen, F, Fliessbach, K et al.. Level of education mitigates the impact of tau pathology on neuronal function. Eur. J. Nucl. Med. Mol. Imaging. 2019;46 (9):1787-1795. doi: 10.1007/s00259-019-04342-3. PubMed PMID:31183635 .
  14. Trampenau, L, Kuhtz-Buschbeck, JP, van Eimeren, T. Parkinsonian patients do not utilize probabilistic advance information in a grip-lift task. Parkinsonism Relat. Disord. 2019;65 :67-72. doi: 10.1016/j.parkreldis.2019.05.015. PubMed PMID:31105014 .
  15. van Eimeren, T, Antonini, A, Berg, D, Bohnen, N, Ceravolo, R, Drzezga, A et al.. Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility System. Alzheimers Dement (Amst). 2019;11 :301-309. doi: 10.1016/j.dadm.2019.01.011. PubMed PMID:30984816 PubMed Central PMC6446052.
  16. Yilmaz, R, Hopfner, F, van Eimeren, T, Berg, D. Biomarkers of Parkinson's disease: 20 years later. J Neural Transm (Vienna). 2019;126 (7):803-813. doi: 10.1007/s00702-019-02001-3. PubMed PMID:30949837 .
  17. Grimm, MJ, Respondek, G, Stamelou, M, Arzberger, T, Ferguson, L, Gelpi, E et al.. How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsy. Mov. Disord. 2019;34 (8):1228-1232. doi: 10.1002/mds.27666. PubMed PMID:30884545 PubMed Central PMC6699888.
  18. Giehl, K, Tahmasian, M, Eickhoff, SB, van Eimeren, T. Imaging executive functions in Parkinson's disease: An activation likelihood estimation meta-analysis. Parkinsonism Relat. Disord. 2019;63 :137-142. doi: 10.1016/j.parkreldis.2019.02.015. PubMed PMID:30833230 .
  19. Hammes, J, Theis, H, Giehl, K, Hoenig, MC, Greuel, A, Tittgemeyer, M et al.. Dopamine metabolism of the nucleus accumbens and fronto-striatal connectivity modulate impulse control. Brain. 2019;142 (3):733-743. doi: 10.1093/brain/awz007. PubMed PMID:30753324 .
  20. Strafella, AP, Bohnen, NI, Pavese, N, Vaillancourt, DE, van Eimeren, T, Politis, M et al.. Imaging Markers of Progression in Parkinson's Disease. Mov Disord Clin Pract. ;5 (6):586-596. doi: 10.1002/mdc3.12673. PubMed PMID:30637278 PubMed Central PMC6277366.
  21. Hammes, J, Hohberg, M, Täger, P, Wild, M, Zlatopolskiy, B, Krapf, P et al.. Uptake in non-affected bone tissue does not differ between [18F]-DCFPyL and [68Ga]-HBED-CC PSMA PET/CT. PLoS ONE. 2018;13 (12):e0209613. doi: 10.1371/journal.pone.0209613. PubMed PMID:30571794 PubMed Central PMC6301686.
  22. Hammes, J, van Heek, L, Hohberg, M, Reifegerst, M, Stockter, S, Dietlein, M et al.. Impact of different approaches to calculation of treatment activities on achieved doses in radioiodine therapy of benign thyroid diseases. EJNMMI Phys. 2018;5 (1):32. doi: 10.1186/s40658-018-0231-x. PubMed PMID:30539323 PubMed Central PMC6289932.
  23. Baumann, A, Nebel, A, Granert, O, Giehl, K, Wolff, S, Schmidt, W et al.. Neural Correlates of Hypokinetic Dysarthria and Mechanisms of Effective Voice Treatment in Parkinson Disease. Neurorehabil Neural Repair. 2018;32 (12):1055-1066. doi: 10.1177/1545968318812726. PubMed PMID:30444176 .
  24. Hammes, J, Drzezga, A, van Eimeren, T. The Role of Tau Imaging in Parkinsonian Disorders. Curr Neurol Neurosci Rep. 2018;18 (12):86. doi: 10.1007/s11910-018-0898-3. PubMed PMID:30293094 .
  25. Dodel, R, Koschel, J, Lorenzl, S, Levin, J, van Eimeren, T, Höglinger, G et al.. [Dementia with Lewy bodies]. Fortschr Neurol Psychiatr. 2018;86 (S 01):S43-S47. doi: 10.1055/a-0696-6249. PubMed PMID:30241100 .
  26. Kovacs, GG, Respondek, G, van Eimeren, T, Höller, E, Levin, J, Müller, U et al.. [Tauopathies : From molecule to therapy]. Nervenarzt. 2018;89 (10):1083-1094. doi: 10.1007/s00115-018-0584-3. PubMed PMID:30120488 .
  27. Hohberg, M, Kobe, C, Täger, P, Hammes, J, Schmidt, M, Dietlein, F et al.. Combined Early and Late [Ga]PSMA-HBED-CC PET Scans Improve Lesion Detectability in Biochemical Recurrence of Prostate Cancer with Low PSA Levels. Mol Imaging Biol. 2019;21 (3):558-566. doi: 10.1007/s11307-018-1263-2. PubMed PMID:30105521 .
  28. Chong, TT, Apps, MAJ, Giehl, K, Hall, S, Clifton, CH, Husain, M et al.. Computational modelling reveals distinct patterns of cognitive and physical motivation in elite athletes. Sci Rep. 2018;8 (1):11888. doi: 10.1038/s41598-018-30220-3. PubMed PMID:30089782 PubMed Central PMC6082862.
  29. Ring, P, Probst, CC, Neyse, L, Wolff, S, Kaernbach, C, van Eimeren, T et al.. It's all about gains: Risk preferences in problem gambling. J Exp Psychol Gen. 2018;147 (8):1241-1255. doi: 10.1037/xge0000418. PubMed PMID:29878809 .
  30. Schweyer, K, Busche, MA, Hammes, J, Zwergal, A, Buhmann, C, van Eimeren, T et al.. Pearls & Oy-sters: Ocular motor apraxia as essential differential diagnosis to supranuclear gaze palsy: Eyes up. Neurology. 2018;90 (10):482-485. doi: 10.1212/WNL.0000000000005069. PubMed PMID:29507134 .
  31. Schwartz, F, Tahmasian, M, Maier, F, Rochhausen, L, Schnorrenberg, KL, Samea, F et al.. Overlapping and distinct neural metabolic patterns related to impulsivity and hypomania in Parkinson's disease. Brain Imaging Behav. 2019;13 (1):241-254. doi: 10.1007/s11682-017-9812-x. PubMed PMID:29322397 .
  32. Hoenig, MC, Bischof, GN, Seemiller, J, Hammes, J, Kukolja, J, Onur, ÖA et al.. Networks of tau distribution in Alzheimer's disease. Brain. 2018;141 (2):568-581. doi: 10.1093/brain/awx353. PubMed PMID:29315361 .
  33. Hammes, J, Täger, P, Drzezga, A. EBONI: A Tool for Automated Quantification of Bone Metastasis Load in PSMA PET/CT. J. Nucl. Med. 2018;59 (7):1070-1075. doi: 10.2967/jnumed.117.203265. PubMed PMID:29242401 .
  34. Hammes, J, Leuwer, I, Bischof, GN, Drzezga, A, van Eimeren, T. Multimodal correlation of dynamic [F]-AV-1451 perfusion PET and neuronal hypometabolism in [F]-FDG PET. Eur. J. Nucl. Med. Mol. Imaging. 2017;44 (13):2249-2256. doi: 10.1007/s00259-017-3840-z. PubMed PMID:29026951 .
  35. Hammes, J, Kobe, C, Hilgenberg, U, Lieb, WE, Drzezga, A. Orbital Hemangiopericytoma in 68Ga-Prostate-Specific Membrane Antigen-HBED-CC PET/CT. Clin Nucl Med. 2017;42 (10):812-814. doi: 10.1097/RLU.0000000000001791. PubMed PMID:28806257 .
  36. Bischof, GN, Endepols, H, van Eimeren, T, Drzezga, A. Tau-imaging in neurodegeneration. Methods. 2017;130 :114-123. doi: 10.1016/j.ymeth.2017.08.003. PubMed PMID:28790016 .
  37. Hoenig, MC, Bischof, GN, Hammes, J, Faber, J, Fliessbach, K, van Eimeren, T et al.. Tau pathology and cognitive reserve in Alzheimer's disease. Neurobiol. Aging. 2017;57 :1-7. doi: 10.1016/j.neurobiolaging.2017.05.004. PubMed PMID:28577411 .
  38. Kreutzer, C, Peters, S, Schulte, DM, Fangmann, D, Türk, K, Wolff, S et al.. Hypothalamic Inflammation in Human Obesity Is Mediated by Environmental and Genetic Factors. Diabetes. 2017;66 (9):2407-2415. doi: 10.2337/db17-0067. PubMed PMID:28576837 .
  39. Farrell, ME, Kennedy, KM, Rodrigue, KM, Wig, G, Bischof, GN, Rieck, JR et al.. Association of Longitudinal Cognitive Decline With Amyloid Burden in Middle-aged and Older Adults: Evidence for a Dose-Response Relationship. JAMA Neurol. 2017;74 (7):830-838. doi: 10.1001/jamaneurol.2017.0892. PubMed PMID:28558099 PubMed Central PMC5710531.
  40. Respondek, G, Kurz, C, Arzberger, T, Compta, Y, Englund, E, Ferguson, LW et al.. Which ante mortem clinical features predict progressive supranuclear palsy pathology?. Mov. Disord. 2017;32 (7):995-1005. doi: 10.1002/mds.27034. PubMed PMID:28500752 PubMed Central PMC5543934.
  41. Whitwell, JL, Höglinger, GU, Antonini, A, Bordelon, Y, Boxer, AL, Colosimo, C et al.. Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?. Mov. Disord. 2017;32 (7):955-971. doi: 10.1002/mds.27038. PubMed PMID:28500751 PubMed Central PMC5511762.
  42. van Eimeren, T, Bischof, GN, Drzezga, A. Is Tau Imaging More Than Just Upside-Down F-FDG Imaging?. J. Nucl. Med. 2017;58 (9):1357-1359. doi: 10.2967/jnumed.117.190082. PubMed PMID:28490468 .
  43. Tahmasian, M, Eickhoff, SB, Giehl, K, Schwartz, F, Herz, DM, Drzezga, A et al.. Resting-state functional reorganization in Parkinson's disease: An activation likelihood estimation meta-analysis. Cortex. 2017;92 :119-138. doi: 10.1016/j.cortex.2017.03.016. PubMed PMID:28467917 .
  44. Höglinger, GU, Respondek, G, Stamelou, M, Kurz, C, Josephs, KA, Lang, AE et al.. Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria. Mov. Disord. 2017;32 (6):853-864. doi: 10.1002/mds.26987. PubMed PMID:28467028 PubMed Central PMC5516529.
  45. Chong, TT, Apps, M, Giehl, K, Sillence, A, Grima, LL, Husain, M et al.. Neurocomputational mechanisms underlying subjective valuation of effort costs. PLoS Biol. 2017;15 (2):e1002598. doi: 10.1371/journal.pbio.1002598. PubMed PMID:28234892 PubMed Central PMC5325181.
  46. Strafella, AP, Bohnen, NI, Perlmutter, JS, Eidelberg, D, Pavese, N, Van Eimeren, T et al.. Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers. Mov. Disord. 2017;32 (2):181-192. doi: 10.1002/mds.26907. PubMed PMID:28150432 .
  47. Bischof, GN, Jessen, F, Fliessbach, K, Dronse, J, Hammes, J, Neumaier, B et al.. Impact of tau and amyloid burden on glucose metabolism in Alzheimer's disease. Ann Clin Transl Neurol. 2016;3 (12):934-939. doi: 10.1002/acn3.339. PubMed PMID:28097205 PubMed Central PMC5224823.
  48. Zokaei, N, Giehl, K, Sillence, A, Neville, MJ, Karpe, F, Nobre, AC et al.. Sex and APOE: A memory advantage in male APOE ε4 carriers in midlife. Cortex. 2017;88 :98-105. doi: 10.1016/j.cortex.2016.12.016. PubMed PMID:28086184 PubMed Central PMC5333781.
  49. Trampenau, L, van Eimeren, T, Kuhtz-Buschbeck, J. Processing of probabilistic information in weight perception and motor prediction. Atten Percept Psychophys. 2017;79 (2):404-414. doi: 10.3758/s13414-016-1266-5. PubMed PMID:28035624 .
  50. Bischof, GN, Rodrigue, KM, Kennedy, KM, Devous, MD Sr, Park, DC. Amyloid deposition in younger adults is linked to episodic memory performance. Neurology. 2016;87 (24):2562-2566. doi: 10.1212/WNL.0000000000003425. PubMed PMID:27837001 PubMed Central PMC5207002.
  51. Dronse, J, Fliessbach, K, Bischof, GN, von Reutern, B, Faber, J, Hammes, J et al.. In vivo Patterns of Tau Pathology, Amyloid-β Burden, and Neuronal Dysfunction in Clinical Variants of Alzheimer's Disease. J. Alzheimers Dis. 2017;55 (2):465-471. doi: 10.3233/JAD-160316. PubMed PMID:27802224 .
  52. Hammes, J, Bischof, GN, Giehl, K, Faber, J, Drzezga, A, Klockgether, T et al.. Elevated in vivo [18F]-AV-1451 uptake in a patient with progressive supranuclear palsy. Mov. Disord. 2017;32 (1):170-171. doi: 10.1002/mds.26727. PubMed PMID:27476874 .
  53. McDonough, IM, Bischof, GN, Kennedy, KM, Rodrigue, KM, Farrell, ME, Park, DC et al.. Discrepancies between fluid and crystallized ability in healthy adults: a behavioral marker of preclinical Alzheimer's disease. Neurobiol. Aging. 2016;46 :68-75. doi: 10.1016/j.neurobiolaging.2016.06.011. PubMed PMID:27460151 PubMed Central PMC5018443.
  54. Rempe, T, Kuhlenbäumer, G, Krüger, S, Biskup, S, Matschke, J, Hagel, C et al.. Early-onset parkinsonism due to compound heterozygous POLG mutations. Parkinsonism Relat. Disord. 2016;29 :135-7. doi: 10.1016/j.parkreldis.2016.04.020. PubMed PMID:27185166 .
  55. Achilles, EI, Maus, V, Fink, GR, Maintz, D, van Eimeren, T, Mpotsaris, A et al.. [Hemichorea with Contralateral High Signal Intensity Putaminal Lesion on T1-Weighted Images in Non-Ketotic Hyperglycemia]. Fortschr Neurol Psychiatr. 2016;84 (4):222-5. doi: 10.1055/s-0042-104347. PubMed PMID:27100847 .
  56. Lorenzen, A, Scholz-Hehn, D, Wiesner, CD, Wolff, S, Bergmann, TO, van Eimeren, T et al.. Chemosensory processing in children with attention-deficit/hyperactivity disorder. J Psychiatr Res. 2016;76 :121-7. doi: 10.1016/j.jpsychires.2016.02.007. PubMed PMID:26926800 .
  57. Zeuner, KE, Knutzen, A, Granert, O, Sablowsky, S, Götz, J, Wolff, S et al.. Altered brain activation in a reversal learning task unmasks adaptive changes in cognitive control in writer's cramp. Neuroimage Clin. 2016;10 :63-70. doi: 10.1016/j.nicl.2015.11.006. PubMed PMID:26702397 PubMed Central PMC4669532.
  58. Tahmasian, M, Rochhausen, L, Maier, F, Williamson, KL, Drzezga, A, Timmermann, L et al.. Impulsivity is Associated with Increased Metabolism in the Fronto-Insular Network in Parkinson's Disease. Front Behav Neurosci. 2015;9 :317. doi: 10.3389/fnbeh.2015.00317. PubMed PMID:26648853 PubMed Central PMC4664667.
  59. Rolinski, M, Zokaei, N, Baig, F, Giehl, K, Quinnell, T, Zaiwalla, Z et al.. Visual short-term memory deficits in REM sleep behaviour disorder mirror those in Parkinson's disease. Brain. 2016;139 (Pt 1):47-53. doi: 10.1093/brain/awv334. PubMed PMID:26582557 PubMed Central PMC4949392.
  60. McDonough, IM, Haber, S, Bischof, GN, Park, DC. The Synapse Project: Engagement in mentally challenging activities enhances neural efficiency. Restor. Neurol. Neurosci. 2015;33 (6):865-82. doi: 10.3233/RNN-150533. PubMed PMID:26484698 PubMed Central PMC4927925.
  61. Ponseti, J, Granert, O, Van Eimeren, T, Jansen, O, Wolff, S, Beier, K et al.. Assessing paedophilia based on the haemodynamic brain response to face images. World J. Biol. Psychiatry. 2016;17 (1):39-46. doi: 10.3109/15622975.2015.1083612. PubMed PMID:26452682 .
  62. Tahmasian, M, Bettray, LM, van Eimeren, T, Drzezga, A, Timmermann, L, Eickhoff, CR et al.. A systematic review on the applications of resting-state fMRI in Parkinson's disease: Does dopamine replacement therapy play a role?. Cortex. 2015;73 :80-105. doi: 10.1016/j.cortex.2015.08.005. PubMed PMID:26386442 .
  63. Granert, O, Drzezga, AE, Boecker, H, Perneczky, R, Kurz, A, Götz, J et al.. Metabolic Topology of Neurodegenerative Disorders: Influence of Cognitive and Motor Deficits. J. Nucl. Med. 2015;56 (12):1916-21. doi: 10.2967/jnumed.115.156067. PubMed PMID:26383147 .
  64. Probst, CC, Winter, LM, Möller, B, Weber, H, Weintraub, D, Witt, K et al.. Erratum to: Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease (QUIP) and the QUIP-rating scale in a German speaking sample. J. Neurol. 2015;262 (9):2200. doi: 10.1007/s00415-015-7882-5. PubMed PMID:26338812 PubMed Central PMC4713996.
  65. Gerwinn, H, Pohl, A, Granert, O, van Eimeren, T, Wolff, S, Jansen, O et al.. The (in)consistency of changes in brain macrostructure in male paedophiles: A combined T1-weighted and diffusion tensor imaging study. J Psychiatr Res. 2015;68 :246-53. doi: 10.1016/j.jpsychires.2015.07.002. PubMed PMID:26228426 .
  66. Bischof, GN, Park, DC. Obesity and Aging: Consequences for Cognition, Brain Structure, and Brain Function. Psychosom Med. ;77 (6):697-709. doi: 10.1097/PSY.0000000000000212. PubMed PMID:26107577 PubMed Central PMC5648343.
  67. Paschen, L, Schmidt, N, Wolff, S, Cnyrim, C, van Eimeren, T, Zeuner, KE et al.. The olfactory bulb volume in patients with idiopathic Parkinson's disease. Eur. J. Neurol. 2015;22 (7):1068-73. doi: 10.1111/ene.12709. PubMed PMID:25912367 .
  68. Trampenau, L, Kuhtz-Buschbeck, JP, van Eimeren, T. Probabilistic information on object weight shapes force dynamics in a grip-lift task. Exp Brain Res. 2015;233 (6):1711-20. doi: 10.1007/s00221-015-4244-6. PubMed PMID:25761969 .
  69. Zeuner, KE, Knutzen, A, Granert, O, Götz, J, Wolff, S, Jansen, O et al.. Increased volume and impaired function: the role of the basal ganglia in writer's cramp. Brain Behav. 2015;5 (2):e00301. doi: 10.1002/brb3.301. PubMed PMID:25642386 PubMed Central PMC4309880.
  70. Kennedy, KM, Rodrigue, KM, Bischof, GN, Hebrank, AC, Reuter-Lorenz, PA, Park, DC et al.. Age trajectories of functional activation under conditions of low and high processing demands: an adult lifespan fMRI study of the aging brain. Neuroimage. 2015;104 :21-34. doi: 10.1016/j.neuroimage.2014.09.056. PubMed PMID:25284304 PubMed Central PMC4252495.
  71. Ponseti, J, Granert, O, van Eimeren, T, Jansen, O, Wolff, S, Beier, K et al.. Human face processing is tuned to sexual age preferences. Biol. Lett. 2014;10 (5):20140200. doi: 10.1098/rsbl.2014.0200. PubMed PMID:24850896 PubMed Central PMC4046377.
  72. Probst, CC, Winter, LM, Möller, B, Weber, H, Weintraub, D, Witt, K et al.. Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease (QUIP) and the QUIP-rating scale in a German speaking sample. J. Neurol. 2014;261 (5):936-42. doi: 10.1007/s00415-014-7299-6. PubMed PMID:24609972 PubMed Central PMC4148320.
  73. van Eimeren, T. Is the Pill Questionnaire useless? Your move, MDS Task Force. J. Neurol. Neurosurg. Psychiatry. 2014;85 (9):949. doi: 10.1136/jnnp-2013-307040. PubMed PMID:24357681 .
  74. Park, DC, Lodi-Smith, J, Drew, L, Haber, S, Hebrank, A, Bischof, GN et al.. The impact of sustained engagement on cognitive function in older adults: the Synapse Project. Psychol Sci. 2014;25 (1):103-12. doi: 10.1177/0956797613499592. PubMed PMID:24214244 PubMed Central PMC4154531.
  75. Goerlich-Dobre, KS, Probst, C, Winter, L, Witt, K, Deuschl, G, Möller, B et al.. Alexithymia-an independent risk factor for impulsive-compulsive disorders in Parkinson's disease. Mov. Disord. 2014;29 (2):214-20. doi: 10.1002/mds.25679. PubMed PMID:24123483 .
  76. Probst, CC, van Eimeren, T. The functional anatomy of impulse control disorders. Curr Neurol Neurosci Rep. 2013;13 (10):386. doi: 10.1007/s11910-013-0386-8. PubMed PMID:23963609 PubMed Central PMC3779310.
  77. Witt, K, Granert, O, Daniels, C, Volkmann, J, Falk, D, van Eimeren, T et al.. Relation of lead trajectory and electrode position to neuropsychological outcomes of subthalamic neurostimulation in Parkinson's disease: results from a randomized trial. Brain. 2013;136 (Pt 7):2109-19. doi: 10.1093/brain/awt151. PubMed PMID:23801735 .
  78. Park, DC, Bischof, GN. The aging mind: neuroplasticity in response to cognitive training. Dialogues Clin Neurosci. 2013;15 (1):109-19. . PubMed PMID:23576894 PubMed Central PMC3622463.
  79. Burciu, RG, Fritsche, N, Granert, O, Schmitz, L, Spönemann, N, Konczak, J et al.. Brain changes associated with postural training in patients with cerebellar degeneration: a voxel-based morphometry study. J. Neurosci. 2013;33 (10):4594-604. doi: 10.1523/JNEUROSCI.3381-12.2013. PubMed PMID:23467375 PubMed Central PMC6704968.
  80. Ballesteros, S, Bischof, GN, Goh, JO, Park, DC. Neural correlates of conceptual object priming in young and older adults: an event-related functional magnetic resonance imaging study. Neurobiol. Aging. 2013;34 (4):1254-64. doi: 10.1016/j.neurobiolaging.2012.09.019. PubMed PMID:23102512 PubMed Central PMC4028122.
  81. Katzenschlager, R, Goerlich, KS, van Eimeren, T. [Repetitive impulse-associated behavioral disorders in Parkinson's disease]. Nervenarzt. 2012;83 (12):1582-9. doi: 10.1007/s00115-012-3631-5. PubMed PMID:22878676 .
  82. Kennedy, KM, Rodrigue, KM, Devous, MD Sr, Hebrank, AC, Bischof, GN, Park, DC et al.. Effects of beta-amyloid accumulation on neural function during encoding across the adult lifespan. Neuroimage. 2012;62 (1):1-8. doi: 10.1016/j.neuroimage.2012.03.077. PubMed PMID:22569063 PubMed Central PMC3381050.
  83. Park, J, Carp, J, Kennedy, KM, Rodrigue, KM, Bischof, GN, Huang, CM et al.. Neural broadening or neural attenuation? Investigating age-related dedifferentiation in the face network in a large lifespan sample. J. Neurosci. 2012;32 (6):2154-8. doi: 10.1523/JNEUROSCI.4494-11.2012. PubMed PMID:22323727 PubMed Central PMC3361757.
  84. van Eimeren, T, Ko, JH, Pellechia, G, Cho, SS, Houle, S, Strafella, AP et al.. Prefrontal D2-receptor stimulation mediates flexible adaptation of economic preference hierarchies. Hum Brain Mapp. 2013;34 (1):226-32. doi: 10.1002/hbm.21425. PubMed PMID:22020993 PubMed Central PMC3521779.
  85. Hammes, J, Pietrzyk, U, Schmidt, M, Schicha, H, Eschner, W. GATE based Monte Carlo simulation of planar scintigraphy to estimate the nodular dose in radioiodine therapy for autonomous thyroid adenoma. Z Med Phys. 2011;21 (4):290-300. doi: 10.1016/j.zemedi.2011.09.002. PubMed PMID:21983024 .
  86. Smith, GS, Kahn, A, Sacher, J, Rusjan, P, van Eimeren, T, Flint, A et al.. Serotonin transporter occupancy and the functional neuroanatomic effects of citalopram in geriatric depression. Am J Geriatr Psychiatry. 2011;19 (12):1016-25. doi: 10.1097/JGP.0b013e318227f83f. PubMed PMID:21841458 PubMed Central PMC3968900.
  87. Cilia, R, van Eimeren, T. Impulse control disorders in Parkinson's disease: seeking a roadmap toward a better understanding. Brain Struct Funct. 2011;216 (4):289-99. doi: 10.1007/s00429-011-0314-0. PubMed PMID:21541715 PubMed Central PMC3197927.
  88. Cilia, R, Cho, SS, van Eimeren, T, Marotta, G, Siri, C, Ko, JH et al.. Pathological gambling in patients with Parkinson's disease is associated with fronto-striatal disconnection: a path modeling analysis. Mov. Disord. 2011;26 (2):225-33. doi: 10.1002/mds.23480. PubMed PMID:21284039 .
  89. van Eimeren, T, Pellecchia, G, Cilia, R, Ballanger, B, Steeves, TD, Houle, S et al.. Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD. Neurology. 2010;75 (19):1711-6. doi: 10.1212/WNL.0b013e3181fc27fa. PubMed PMID:20926784 PubMed Central PMC3033606.
  90. Cho, SS, Ko, JH, Pellecchia, G, Van Eimeren, T, Cilia, R, Strafella, AP et al.. Continuous theta burst stimulation of right dorsolateral prefrontal cortex induces changes in impulsivity level. Brain Stimul. 2010;3 (3):170-6. doi: 10.1016/j.brs.2009.10.002. PubMed PMID:20633446 PubMed Central PMC3707839.
  91. van Eimeren, T, Binkofski, F, Buhmann, C, Hagenah, J, Strafella, AP, Pramstaller, PP et al.. Imaging movement-related activity in medicated Parkin-associated and sporadic Parkinson's disease. Parkinsonism Relat. Disord. 2010;16 (6):384-7. doi: 10.1016/j.parkreldis.2010.04.003. PubMed PMID:20434937 .
  92. Ballanger, B, Strafella, AP, van Eimeren, T, Zurowski, M, Rusjan, PM, Houle, S et al.. Serotonin 2A receptors and visual hallucinations in Parkinson disease. Arch. Neurol. 2010;67 (4):416-21. doi: 10.1001/archneurol.2010.35. PubMed PMID:20385906 .
  93. Cilia, R, Ko, JH, Cho, SS, van Eimeren, T, Marotta, G, Pellecchia, G et al.. Reduced dopamine transporter density in the ventral striatum of patients with Parkinson's disease and pathological gambling. Neurobiol. Dis. 2010;39 (1):98-104. doi: 10.1016/j.nbd.2010.03.013. PubMed PMID:20338240 .
  94. Ballanger, B, van Eimeren, T, Moro, E, Lozano, AM, Hamani, C, Boulinguez, P et al.. Stimulation of the subthalamic nucleus and impulsivity: release your horses. Ann. Neurol. 2009;66 (6):817-24. doi: 10.1002/ana.21795. PubMed PMID:20035509 PubMed Central PMC2972250.
  95. van Nuenen, BF, van Eimeren, T, van der Vegt, JP, Buhmann, C, Klein, C, Bloem, BR et al.. Mapping preclinical compensation in Parkinson's disease: an imaging genomics approach. Mov. Disord. 2009;24 Suppl 2 :S703-10. doi: 10.1002/mds.22635. PubMed PMID:19877238 .
  96. van Eimeren, T, Ballanger, B, Pellecchia, G, Miyasaki, JM, Lang, AE, Strafella, AP et al.. Dopamine agonists diminish value sensitivity of the orbitofrontal cortex: a trigger for pathological gambling in Parkinson's disease?. Neuropsychopharmacology. 2009;34 (13):2758-66. doi: 10.1038/npp.2009.124. PubMed PMID:19741594 PubMed Central PMC2972251.
  97. van Eimeren, T, Monchi, O, Ballanger, B, Strafella, AP. Dysfunction of the default mode network in Parkinson disease: a functional magnetic resonance imaging study. Arch. Neurol. 2009;66 (7):877-83. doi: 10.1001/archneurol.2009.97. PubMed PMID:19597090 PubMed Central PMC2972248.
  98. Ballanger, B, Lozano, AM, Moro, E, van Eimeren, T, Hamani, C, Chen, R et al.. Cerebral blood flow changes induced by pedunculopontine nucleus stimulation in patients with advanced Parkinson's disease: a [(15)O] H2O PET study. Hum Brain Mapp. 2009;30 (12):3901-9. doi: 10.1002/hbm.20815. PubMed PMID:19479730 .
  99. Steeves, TD, Miyasaki, J, Zurowski, M, Lang, AE, Pellecchia, G, Van Eimeren, T et al.. Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study. Brain. 2009;132 (Pt 5):1376-85. doi: 10.1093/brain/awp054. PubMed PMID:19346328 PubMed Central PMC3479148.
  100. Ko, JH, Ptito, A, Monchi, O, Cho, SS, Van Eimeren, T, Pellecchia, G et al.. Increased dopamine release in the right anterior cingulate cortex during the performance of a sorting task: a [11C]FLB 457 PET study. Neuroimage. 2009;46 (2):516-21. doi: 10.1016/j.neuroimage.2009.02.031. PubMed PMID:19264140 PubMed Central PMC2972252.
  101. Hammes, J., Bischof, G.N. & Drzezga, A. Clin Transl Imaging (2017) 5: 465. https://doi.org/10.1007/s40336-017-0242-y
Search PubMed